Skip to content

13F-HR filed by Integral Health Asset Management, LLC

Integral Health Asset Management, LLC filed this 13F-HR for the quarter ended 2021-12-31, filed 2022-02-02, with 71 holding rows worth $361,382,000.

Accession
0001420506-22-000109
Filed
2022-02-02
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2021

A holdings report, 71 entries on the cover page, a total value of $361,382,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $361,382,000 with VALUE read as thousands by filing date, 13F file number 028-19946. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CENTENE CORP DEL COM15135B101Stock225,000$18,540,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM409,000$17,399,000thousands by filing date
CYTOKINETICS INC23282W605COM NEW325,000$14,814,000thousands by filing date
REVVITY INC714046109COM70,000$14,074,000thousands by filing date
MCKESSON CORP COM58155Q103Stock55,000$13,671,000thousands by filing date
ENVISTA HOLDINGS CORPORATION29415F104COM300,000$13,518,000thousands by filing date
GLOBUS MED INC CL A379577208Stock180,000$12,996,000thousands by filing date
Pfizer Inc.717081103COM200,000$11,810,000thousands by filing date
Elevance Health, Inc.036752103COM25,000$11,589,000thousands by filing date
ZENTALIS PHARMACEUTICALS INC98943L107COMMON STOCK120,000$10,087,000thousands by filing date
Abbott Laboratories002824100COM70,000$9,852,000thousands by filing date
CVS Health Corporation126650100COM85,000$8,769,000thousands by filing date
BIOGEN INC COM09062X103Stock35,000$8,397,000thousands by filing date
AMEDISYS INC023436108COM50,000$8,094,000thousands by filing date
BLUEPRINT MEDICINES CORP09627Y109COM75,000$8,033,000thousands by filing date
FATE THERAPEUTICS INC31189P102COM130,000$7,606,000thousands by filing date
ACADIA HEALTHCARE COMPANY INC COM00404A109Stock120,000$7,284,000thousands by filing date
CHEMOCENTRYX INC16383L106COM200,000$7,282,000thousands by filing date
RELAY THERAPEUTICS INC COM75943R102Stock225,000$6,910,000thousands by filing date
HERON THERAPEUTICS INC427746102COM750,000$6,848,000thousands by filing date
AbbVie,Inc.00287Y109COM50,000$6,770,000thousands by filing date
TENET HEALTHCARE CORP COM NEW88033G407Stock80,000$6,535,000thousands by filing date
LABORATORY CORP OF AMERICA50540R409COM NEW20,000$6,284,000thousands by filing date
INTELLIA THERAPEUTICS INC45826J105COM50,000$5,912,000thousands by filing date
EDWARDS LIFESCIENCES CORP COM28176E108Stock45,000$5,830,000thousands by filing date
ASTRAZENECA PLC SPONSORED ADR046353108ADR100,000$5,825,000thousands by filing date
APELLIS PHARMACEUTICALS INC03753U106COM120,000$5,674,000thousands by filing date
1LIFE HEALTHCARE INC68269G107COM275,000$4,832,000thousands by filing date
IRHYTHM HOLDINGS INC COM450056106Stock40,000$4,708,000thousands by filing date
DENALI THERAPEUTICS INC COM24823R105Stock100,000$4,460,000thousands by filing date
GLAXOSMITHKLINE PLC-ADR37733W105SPONSORED ADR100,000$4,410,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM48,000$4,241,000thousands by filing date
SI BONE INC825704109COM175,000$3,887,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock20,000$3,392,000thousands by filing date
AGILON HEALTH INC00857U107COM125,000$3,375,000thousands by filing date
ARROWHEAD PHARMACEUTICALS IN04280A100COM50,000$3,315,000thousands by filing date
HORIZON THERAPEUTICS PLCG46188101SHS30,000$3,233,000thousands by filing date
ATARA BIOTHERAPEUTICS INC COM NEW046513107Stock200,000$3,152,000thousands by filing date
MASIMO CORP COM574795100Stock10,000$2,928,000thousands by filing date
ACLARIS THERAPEUTICS INC COM00461U105Stock200,000$2,908,000thousands by filing date
NEVRO CORP64157F103COM35,000$2,837,000thousands by filing date
AVALO THERAPEUTICS INC05338F108CMN1,625,000$2,763,000thousands by filing date
REATA PHARMACEUTICALS INC75615P103CL A103,000$2,716,000thousands by filing date
REPLIMUNE GROUP INC76029N106COMMON STOCK100,000$2,710,000thousands by filing date
BRIDGEBIO PHARMA INC10806X902COM150,000$2,502,000thousands by filing datecall
REGENXBIO INC75901B107COM75,000$2,453,000thousands by filing date
ARCTURUS THERAPEUTICS HLDGS03969T109COM65,000$2,406,000thousands by filing date
ITEOS THERAPEUTICS INC46565G104COM50,000$2,328,000thousands by filing date
INCYTE CORP COM45337C102Stock30,000$2,202,000thousands by filing date
INSMED INC COM PAR $.01457669307Stock80,000$2,179,000thousands by filing date
MACROGENICS INC556099109COM130,000$2,087,000thousands by filing date
UNIQURE NVN90064101SHS100,000$2,074,000thousands by filing date
KEROS THERAPEUTICS INC COM492327101Stock35,000$2,048,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM175,000$2,021,000thousands by filing date
IMMUNOGEN INC45253H101COMMON STOCK250,000$1,855,000thousands by filing date
AKERO THERAPEUTICS INC00973Y108COM85,000$1,798,000thousands by filing date
PTC THERAPEUTICS INC69366J200COM45,000$1,792,000thousands by filing date
KINIKSA PHARMACEUTICALS LTDG5269C101COM CL A140,000$1,648,000thousands by filing date
MIRUM PHARMACEUTICALS INC604749101COM100,000$1,595,000thousands by filing date
PRECISION BIOSCIENCES INC74019P108COM175,000$1,295,000thousands by filing date
INTERCEPT PHARMACEUTICALS IN45845P108COM75,000$1,222,000thousands by filing date
KURA ONCOLOGY INC COM50127T109Stock85,000$1,190,000thousands by filing date
ALKERMES PLCG01767105SHS50,000$1,163,000thousands by filing date
LYELL IMMUNOPHARMA INC55083R104COM140,000$1,084,000thousands by filing date
FORMA THERAPEUTICS HLDGS INC34633R104SHS75,000$1,067,000thousands by filing date
LEXICON PHARMACEUTICALS INC528872302COMMON STOCK200,000$788,000thousands by filing date
CHIMERIX INC COM16934W106Stock110,000$707,000thousands by filing date
AMARIN CORP PLC023111206SPONS ADR NEW200,000$674,000thousands by filing date
DIANTHUS THERAPEUTICS INC COM55910K108Stock90,000$399,000thousands by filing date
MYOVANT SCIENCES LTDG637AM102COMMON STOCK-FO25,000$389,000thousands by filing date
LONGBOARD PHARMACEUTICALS IN54300N103COM30,000$146,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-22-000109this filing2022-02-02acceptance time not in the bulk data set